1 Reason to Buy NuScale Power Stock, and 2 Reasons to Sell

NuScale Power has the only NRC design certification for its 50 MW and 77 MW small modular reactor modules, but it has yet to bring any SMR online. A prior Utah project ballooned from $3 billion to $9.3 billion before being canceled, and the company faces scrutiny, class-action lawsuits, and potentially up to $3 billion in milestone payments tied to the ENTRA1/TVA commercialization effort. The stock remains a high-risk speculative story despite the long-term AI-driven demand thesis for nuclear power.

Analysis

The market is starting to price SMR like a platform winner, but the economics still look like an option on future regulatory and financing credibility rather than a compounding operating business. The first-order story is scarcity value from certification; the second-order issue is that certification may accelerate competition by lowering the credibility hurdle for larger industrials, utilities, and sovereign-backed entrants to replicate the path faster than NuScale can secure bankable projects.

The larger hidden risk is that milestone-heavy commercialization structurally transfers cash-flow timing risk back to NuScale before any durable revenue base exists. That creates a negative feedback loop: every new headline deal may increase near-term cash obligations and litigation exposure without improving visibility on normalized returns, so equity dilution or balance-sheet stress becomes a real 12-24 month catalyst if the project funnel does not convert. In other words, the stock can rerate higher on announcements, but fundamental de-rating can arrive abruptly if one more flagship deployment slips.

From a thematic standpoint, the biggest beneficiaries are not necessarily SMR developers but the adjacent “picks-and-shovels” stack: reactor component suppliers, EPC firms with nuclear qualifications, and regulated utilities that can monetize capacity without carrying pure-technology execution risk. The AI power bottleneck supports the secular thesis for nuclear, but the more investable trade may be that hyperscalers ultimately prefer contracted power from balance-sheet-heavy utilities over development-stage vendors, which caps the terminal multiple NuScale deserves.

Consensus may be underestimating how long the commercialization gap can persist even with policy support. The next few quarters likely trade on press releases and legal headlines; the next few years will be decided by whether one project reaches financing close and construction without a cost-reset. Until then, the name should behave more like a volatility event than a fundamentals compounder.

Key Decisions for Investors

• Avoid initiating a long SMR core position here; if holding, reduce on any announcement-driven spike and treat rallies as liquidity events rather than confirmation of business model success.
• For traders who want nuclear exposure, prefer a basket long in regulated utilities or nuclear supply-chain names over SMR for a 6-18 month horizon; the risk/reward is better because monetization is tied to contracted assets rather than prototype execution.
• Pair trade idea: short SMR / long a utility or infrastructure beneficiary tied to AI power demand, sized for 3-6 months; the spread should capture the gap between narrative value and cash-flow certainty.
• If using options, consider buying puts or put spreads on SMR into any financing- or litigation-related catalyst over the next 1-2 quarters; downside can accelerate quickly if project milestones slip again.
• Do not short purely on the nuclear theme itself; instead, wait for evidence of deal slippage or cash burn inflection, because sentiment can stay elevated until one financing milestone fails.